Insiders Clearside Biomedical, Inc.

Equities

CLSD

US1850631045

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
1.23 ^USD	-1.60%		-3.91%	+5.13%

05-13	HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating	MT
05-09	Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors	04-16	CI
Clearside Biomedical Names Victor Chong Chief Medical Officer	03-18	MT
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer	03-18	CI
Clearside Biomedical, Inc. Announces Appointment to Its Scientific Advisory Board	06/04/23	CI
Clearside Biomedical, Inc. Executive Changes, Effective February 17, 2023	06/02/23	CI
Clearside Biomedical, Inc. Appoints Susan Coultas as Chief Clinical Officer	14/06/22	CI
Clearside Biomedical, Inc. Appoints Benjamin R. Yerxa to Its Board of Directors	03/03/22	CI
Insider Trends: Clearside Biomedical Sees 90 Days of Insider Buying Trend Easing with Share Sale	15/02/21	MT
Insider Trends: Insider Purchase Adds to Clearside Biomedical Positive Trend	07/01/21	MT
Insider Trends: Insider Buying Extended with Purchase of Clearside Biomedical Shares	02/12/20	MT
Insider Trends: Insider Buying Prolonged with Purchase of Clearside Biomedical Shares	24/11/20	MT
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Clearside Biomedical Stock	16/11/20	MT
Clearside Biomedical, Inc Appoints Nancy J. Hutson to Its Board of Directors	22/04/20	CI
Clearside Biomedical, Inc Announces Board Appointments	09/04/20	CI
Clearside Biomedical Appoints George Lasezkay as President and Chief Executive Officer	11/03/20	CI
Clearside Biomedical Announces Management Changes	08/04/19	CI
Clearside Biomedical, Inc. Announces Resignation of Glenn Noronha as Chief Scientific Officer, Effective from December 1, 2018	13/11/18	CI
Clearside Biomedical, Inc. Appoints Thomas A. Ciulla as Chief Medical Officer	25/10/18	CI
Clearside Biomedical, Inc. Appoints Thomas Crawford as Vice President, Supply Chain	19/10/18	CI
Clearside Biomedical, Inc. Announces Executive Changes	26/09/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Clearside Biomedical, Inc.

Equities

CLSD

US1850631045

Insiders

Filters